Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 70

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part I, Item 8
Chunk 70
---
 as redeemable ordinary shares and non-redeemable ordinary shares. Income and losses
are shared pro rata between the two classes of ordinary shares. This presentation assumes a Business Combination as the most likely outcome.
Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding
for the respective period.

The
calculation of diluted net income (loss) per ordinary share does not consider the effect of the rights issued in connection with the
Initial Public Offering and the private placement of the Private Placement Units to receive an aggregate of 2,928,750 ordinary shares
in the calculation of diluted income (loss) per ordinary share, because their issuance is contingent upon future events.

The
Company has considered the effect of non-redeemable ordinary shares that were excluded from weighted average number as they were contingent
on the exercise of over-allotment option by the underwriters. Since the contingency was satisfied, the Company included these shares
in the weighted average number as of the beginning of the interim period to determine the dilutive impact of these shares.

The
following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per ordinary
share for each class of ordinary shares:

    Three Months
    Ended September 30,  
    Nine Months
    Ended September 30, 

    2025  
    2025 

    Redeemable
    shares  
    Non-redeemable
    shares  
    Redeemable
    shares  
    Non-redeemable
    shares 
  
    Basic net income per share: 

    Numerator: 

    Allocation of
    net income 
    $1,499,082  
    $685,481  
    $3,813,036  
    $1,914,649 
  
    Denominator: 

    Weighted-average shares outstanding 
     23,000,000  
     10,517,143  
     20,336,996  
     10,211,868 
  
    Basic
    net income per ordinary share 
    $0.07  
    $0.07  
    $0.19  
    $0.19 

    Diluted net income per share: 

    Numerator: 

    Allocation of net income 
    $1,499,082  
    $685,